Mr. Platteeuw holds a master’s degree in Chemistry from the University of Nijmegen, The Netherlands. He started his career at Synthon BV as Project Manager of pharmaceutical product development and later became the company’s Head of Galenical R&D. In 2004 he moved to Dafra Pharma, a private company specialized in antimalarial medication where he acted as Director R&D and was instrumental for the launch of Co-Arinate. In 2005, he started Avivia BV, a company specialized in pharmaceutical product development with a specific expertise in the development and intellectual property protection of specialty generics products.

After schooling in Tanzania, India and the UK, Mr. Krishna completed BSc and MSc degrees in Electrical Engineering and Operational Research at Imperial College London. During his PhD, he then was headhunted to work as a strategy analyst and later project manager for Lucas Industries in London. Subsequently, he moved to Germany and ran various family businesses in branches as diverse as textiles and paper coatings. After selling the largest German business in 2020, he explored more philanthropic enterprises, and Pamoja b.v. was founded in 2024.